1. GENERAL INFORMATION
1.1 Oxytetracycline Ointment 1% (oksitetratsiklin ointment) in veterinary.
1.2 Each g of ointment contains 10 mg (1000ME) oxytetracycline in the form of hydrochloride
1.3 The ointment by its appearance is a dense homogeneous mass of light-yellow to brown color.
1.4 The drug is pre-packed in polymer container by 100 and 500 g.
1.5 The drug should be stored in a dry and dark place, away from children at the temperature range from +4°C to +25°C. Shelf-life is 1 year under specified storage conditions.
2. PHARMACOLOGICAL PROPERTIES
2.1 Oxytetracycline as an ingredient in the ointment is an antibiotic with a wide range of actions; it is active against Gram-positive and Gram-negative organisms, Rickettsia, TRIC agents and ornithosis.
2.2 Mechanism of antibacterial action is inhibition of microbial cell’s protein synthesis at the ribosome level.
3. DRUG USAGE PROCEDURE
3.1 The ointment is used in treatment of eye infections in animals: conjunctivitis, blepharitis, trachoma, corneal and other eye disease caused by pathogens sensitive to oxytetracycline.
3.2 The ointment is applied by glass spatula on lower animal’s eyelid and by gentle massaging motion with cotton swab it is distributed from eyelid outer side throughout conjunctival sac. The ointment is used 3-5 times a day until recovery. The ointment dosage is 0.2 to 0.4 g per animal depending on severity of disease.
3.3 The ointment causes no complications and has no side effects. There are no contraindications. Restricted use is animal’s individual hypersensitivity to oxytetracycline.
3.4 Slaughter of animals for meat and use of milk for human consumption during ointment applying is not restricted.
4. CLAIMS PROCEDURE
4.1 In case of inconsistency of the drug with requirements of this Instruction, its use should be discontinued and reported to the Uzbek State Scientific and Veterinary Drugs Control Laboratory at: 700178, Tashkent, No.1a, A.Yunusov Street. Tel. / Fax: 228-76-14, 229-30 - 47. E-mail: email@example.com. Simultaneously unpacked drug package should be sent to the laboratory address with the drug in quantity previously agreed with laboratory including detailed description of the nature of complaints regarding its inconsistency with this Instruction.